Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer. (Q48018929)

From Wikidata

Jump to navigation Jump to search

scientific article published on 15 March 2012

Language	Label	Description	Also known as
English	Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.	scientific article published on 15 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

apoptotic process

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Fotios Loupakis

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Carmine Tinelli

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Alfredo Falcone

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Mariangela Manzoni

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Silvia Brugnatelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Eugenio Villa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Marco Danova

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

15 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1187-1196

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

The multifaceted circulating endothelial cell in cancer: towards marker and target identification.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Molecular and cellular biomarkers for angiogenesis in clinical oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Biomarkers and surrogate end points--the challenge of statistical validation

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Metronomic cyclophosphamide and capecitabine combined with bevacizumab in advanced breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Circulating endothelial cells and circulating progenitor cells in breast cancer: relationship to endothelial damage/dysfunction/apoptosis, clinicopathologic factors, and the Nottingham Prognostic Index

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Biomarkers of response and resistance to antiangiogenic therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Circulating endothelial cells as biomarkers in clinical oncology

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Circulating endothelial cells as biomarkers for angiogenesis in tumor progression

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Effective incorporation of biomarkers into phase II trials

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Circulating endothelial cells in oncology: pitfalls and promises

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activity.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1190-6

21 January 2018

Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Flow cytometric detection of circulating endothelial cells and endothelial progenitor cells in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The multiple personality disorder phenotype(s) of circulating endothelial cells in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: a methodological comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers of antiangiogenic therapy: how do we move from candidate biomarkers to valid biomarkers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/22419441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-012-1190-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22419441%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48018929&oldid=2209024948"